Opposing Effects of Alpha 1-adrenergic Receptor Subtypes on Ca2+ and PH Homeostasis in Rat Cardiac Myocytes
Overview
Affiliations
We examined the effect of alpha 1-adrenergic receptor (AR) subtypes on contraction, cytosolic Ca2+ concentration ([Ca2+]i), and cytosolic pH (pHi) of rat ventricular myocytes loaded with the Ca2+ indicator indo 1 or the pH indicator carboxyseminaphthorhodafluor-1. Nonselective alpha 1-AR stimulation was effected with phenylephrine plus nadolol. alpha 1-AR subtype stimulation was achieved with alpha 1-AR and chloroethylclonidine (CEC) or with alpha 1-AR and WB-4101. Cells were in bicarbonate buffer with 0.5 mM Ca2+ and were electrically stimulated at 0.5 Hz. Results show that 1) nonselective alpha 1-AR stimulation increased twitch and [Ca2+]i transient amplitudes, myofilament response to Ca2+, and pHi; 2) alpha 1-AR plus CEC increased twitch and [Ca2+]i transient amplitudes and also enhanced myofilament response to Ca2+ via cytosolic alkalinization; 3) alpha 1-AR plus WB-4101 decreased twitch and [Ca2+]i transient amplitudes and also pHi; and 4) cytosolic acidification due to alpha 1-AR plus WB-4101 was abolished by protein kinase C inhibition (staurosporine pretreatment) or downregulation (prolonged exposure to phorbol esters). In summary, the net effects of alpha 1-adrenergic stimulation on contraction, [Ca2+]i, and pHi are due to opposing WB-4101- and CEC-sensitive alpha 1-AR subtype signaling pathways.
Cowley P, Wang G, Chang A, Makwana O, Swigart P, Lovett D Am J Physiol Heart Circ Physiol. 2015; 309(5):H888-96.
PMID: 26116709 PMC: 4591405. DOI: 10.1152/ajpheart.00042.2015.
Nuclear compartmentalization of α1-adrenergic receptor signaling in adult cardiac myocytes.
Wu S, OConnell T J Cardiovasc Pharmacol. 2014; 65(2):91-100.
PMID: 25264754 PMC: 4320670. DOI: 10.1097/FJC.0000000000000165.
Adrenergic signaling in heart failure: a balance of toxic and protective effects.
Baker A Pflugers Arch. 2014; 466(6):1139-50.
PMID: 24623099 DOI: 10.1007/s00424-014-1491-5.
OConnell T, Jensen B, Baker A, Simpson P Pharmacol Rev. 2013; 66(1):308-33.
PMID: 24368739 PMC: 3880467. DOI: 10.1124/pr.112.007203.
O-Uchi J, Komukai K, Kusakari Y, Morimoto S, Kawai M, Jhun B Biochem Biophys Res Commun. 2013; 433(2):188-93.
PMID: 23454381 PMC: 6554199. DOI: 10.1016/j.bbrc.2013.02.072.